Aging-related studies

Filter by:
Data set Procedure What's in this data set Strains
Tested		 Sex Age Year
Ackert1 body size and weight Body weight, body length, body mass index. Aging study, 6mo, 12mo, 20mo. None BMI, BW inbred  (32) both 26, 52, 87 wks 2008
Ackert1 DXA Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. bone area, body area BMD inbred  (32) both 26, 52, 87 wks 2008
Berndt4 histopathology Lung adenoma frequency and severity at 20mo. Tumor incidence, cancer, aging. None None inbred  (28) both 87wks 2011
Eumorphia2 DXA Body mass, fat mass, lean mass, bone mineral density and content. None BMD inbred  (5) both 12, 24, 52 wks 2008
Eumorphia3 glucose tolerance 0 to 180 min after 20% glucose i.p. 16h fast. None GLU, GTT inbred  (4) both 12, 24, 52 wks 2008
Evsikova1 body weight Body weight None BW inbred  (14) both 26wks 2009
Evsikova1 intake monitoring Food intake, water intake at 6mo. Light phase, dark phase, total. None None inbred  (14) both 26wks 2009
Evsikova1 monitoring system Locomotor activity. Aging study. 24h test with 12h light and 12h dark phases. None None inbred  (14) both 26wks 2009
Hillebrands1 histopathology Kidney pathology at 20mo. perivascular immune cell clusters, aging None inbred  (23) both 87wks 2014
ITP1 body weight Various interventions vs. controls. Lifespan study. fish oil, Protandim, ursodeoxycholic acid, 17-a-estradiol 17aE2, BW, UDCA UM-HET3 population both 2017
ITP1 colony observation Life span study. Various treatments vs. controls. survival, aging, 17-a-estradiol, acarbose, fish oil, metformin, metformin and rapamycin, nordihydroguaiaretic acid, Protandim, ursodeoxycholic acid 17aE2, ACA, NDGA, UDCA UM-HET3 population both 2017
ITP1 grip strength Various interventions vs. controls. Lifespan study. nordihydroguaiaretic acid NDGA UM-HET3 population both 2017
ITP1 uterus weight Uterus weight, ovariectomy study with and without an intervention. Lifespan study. 17-a-estradiol 17aE2 UM-HET3 population both 2017
Johnson1 ABR test Auditory brainstem response. None ABR inbred  (51) both 3-12wks and 15-72wks 2000
Johnson3 ABR test Auditory brainstem response. None ABR B6.A consomic  (24) w/progenitors both 23-30wks 2012
Johnson4 ABR test Auditory brainstem response. None ABR B6.PWD consomic  (28) w/progenitors both 49-63wks 2012
Korstanje1 urinalysis Microalbumin, creatinine, ratio. Aging study, 6mo, 12mo, and 20mo. kidney Alb, CREA, MA inbred  (30) both 52, 78, 104 wks 2008
Korstanje2 histopathology Kidney pathology. Aging study, 6mo, 12mo, 20mo. percent of glomeruli exhibiting mesangial matrix expansion None inbred  (29) m 52, 78, 104 wks 2013
Mills1 apoptosis assessment Aging study, 6mo, 12mo, 20mo. apoptotic splenocytes None inbred  (30) both 26, 52, 87 wks 2008
Mills1 chromosome instability assessment Chromosome instability. Aging study, 6mo, 12mo, 20mo. reticulocytes with micronuclei, cell damage RET, RETIC inbred  (30) both 26, 52, 87 wks 2008
Nelson1 body weight
with restricted diet 		Restricted diet vs. ad libitum diet. None BW ILSXISS  (44) both max lifespan 2010
Nelson1 colony observation
with restricted diet 		Life span comparison. Restricted diet vs. ad libitum diet. survival, aging None ILSXISS  (44) both max lifespan 2010
Nelson1 NMR
with restricted diet 		Body mass, fat mass, lean mass. Restricted diet vs. ad libitum diet. None LTM ILSXISS  (44) both max lifespan 2010
Peters4 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. cell counts, white cells, lymphocytes, neutrophils, monocytes, basophils, eosinophils, large unstained cells, red cell parameters, hemoglobin, hematocrit, reticulocytes, platelets BASO, CBC, RBC, WBC, CHCM, EOS, HCT, HGB, LUC, LYM, MCH, MCHC, MONO, MPV, NEUT, PLT, RET, RETIC inbred  (30) both 26, 52, 78, 104 wks 2007
Petkova1 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. white cell count, lymphocytes, neutrophils, eosinophils, monocytes CBC, RBC, WBC, EOS, LYM, MONO, NEUT inbred  (32) both 26, 52, 78, 104 wks 2007
Petkova1 immune cell quantification Aging study, 6mo, 12mo, 18mo, 24mo. B cells. Natural killer cells, total, mature, T cells total, CD4, CD8, naive, central memory, effector cells None inbred  (32) both 26, 52, 78, 104 wks 2007
Poon1 histopathology Cell proliferation in the rostral migratory stream. BrdU+ cells. None None inbred  (9) both 13-78wks 2013
Seburn2 gait analysis Aging study, 6mo, 18mo. stride length, track width, stride frequency, stance time, swing time, stride time, ratios None inbred  (32) both 26, 52, 78, 104 wks 2008
Seburn2 grip strength Peak tension. 3 trials. Aging study, 6mo, 12mo, 18mo, 24mo. None None inbred  (32) both 26, 52, 78, 104 wks 2008
Sundberg1 study archive Histopathology. Aging study. None None inbred  (28) both 2008
Xing1 ECG Heart rate and wave intervals. Conscious. Aging study, 6mo, 12mo, 20mo. None ECG, EKG, HR inbred  (29) both 26, 52, 87 wks 2008
Xing2 gait analysis Aging study, 6mo, 12mo, 18mo. None None inbred  (31) both 26, 52, 78 wks 2010
Yuan1 body weight Aging study, 6mo, 12mo, and 18mo. None BW inbred  (33) both 26, 52, 78 wks 2007
Yuan1 hormone quantification Insulin-like growth factor 1 (serum). Aging study, 6mo, 12mo, and 18mo. None IGF-1, IGF1, INS inbred  (33) both 26, 52, 78 wks 2007
Yuan2 colony observation Life span study. Survival curves. Aging study. None None inbred  (31) both various 2007
Yuan3 lipid profile Cholesterol (HDL). Aging study, 6mo, 12mo, 18mo. 4h fast, plasma. None CHOL inbred  (32) both 26, 52, 78 wks 2008
Yuan3 metabolic panel Clinical blood chemistry. Aging study, 6mo, 12mo, 18mo. albumin, thyroxine, total protein, bilirubin, urea nitrogen, disolved carbon dioxide. Iron, calcium, chloride, magnesium, phosphorus, potassium, sodium. Alkaline phosphatase, alanine transaminase, lipase ALP, ALT, Alb, BIL, CO2, LIP, T4, TBIL, TP, chem inbred  (32) both 26, 52, 78 wks 2008
Yuan4 colony observation Observed age at vaginal opening (patency). Aging study. None None inbred  (33) f 15-51d 2009